Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study.

Schulman CI, Namias N, Doherty J, Manning RJ, Li P, Elhaddad A, Lasko D, Amortegui J, Dy CJ, Dlugasch L, Baracco G, Cohn SM.

Surg Infect (Larchmt). 2005 Winter;6(4):369-75. Erratum in: Surg Infect (Larchmt). 2010 Oct;11(5):495. Li, Pam [corrected to Li, Pamela]; Alhaddad, Ahmed [corrected to Elhaddad, Ahmed].

PMID:
16433601
2.

Comparison of fever treatments in the critically ill: a pilot study.

Henker R, Rogers S, Kramer DJ, Kelso L, Kerr M, Sereika S.

Am J Crit Care. 2001 Jul;10(4):276-80.

PMID:
11432215
3.

Assessment of the safety and feasibility of administering anti-pyretic therapy in critically ill adults: study protocol of a randomized trial.

Niven DJ, Léger C, Kubes P, Stelfox HT, Laupland KB.

BMC Res Notes. 2012 Mar 16;5:147. doi: 10.1186/1756-0500-5-147.

4.

Assessment of the safety and feasibility of administering antipyretic therapy in critically ill adults: a pilot randomized clinical trial.

Niven DJ, Stelfox HT, Léger C, Kubes P, Laupland KB.

J Crit Care. 2013 Jun;28(3):296-302. doi: 10.1016/j.jcrc.2012.08.015. Epub 2012 Oct 24.

PMID:
23102531
5.

Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study.

Lee BH, Inui D, Suh GY, Kim JY, Kwon JY, Park J, Tada K, Tanaka K, Ietsugu K, Uehara K, Dote K, Tajimi K, Morita K, Matsuo K, Hoshino K, Hosokawa K, Lee KH, Lee KM, Takatori M, Nishimura M, Sanui M, Ito M, Egi M, Honda N, Okayama N, Shime N, Tsuruta R, Nogami S, Yoon SH, Fujitani S, Koh SO, Takeda S, Saito S, Hong SJ, Yamamoto T, Yokoyama T, Yamaguchi T, Nishiyama T, Igarashi T, Kakihana Y, Koh Y; Fever and Antipyretic in Critically ill patients Evaluation (FACE) Study Group.

Crit Care. 2012 Feb 28;16(1):R33. doi: 10.1186/cc11211. Erratum in: Crit Care. 2012;16(1):450.

6.

Acetaminophen has limited antipyretic activity in critically ill patients.

Greenberg RS, Chen H, Hasday JD.

J Crit Care. 2010 Jun;25(2):363.e1-7. doi: 10.1016/j.jcrc.2009.07.005. Epub 2009 Sep 24.

7.

Clinical trial of a novel surface cooling system for fever control in neurocritical care patients.

Mayer SA, Kowalski RG, Presciutti M, Ostapkovich ND, McGann E, Fitzsimmons BF, Yavagal DR, Du YE, Naidech AM, Janjua NA, Claassen J, Kreiter KT, Parra A, Commichau C.

Crit Care Med. 2004 Dec;32(12):2508-15.

PMID:
15599159
8.

Causes and consequences of fever complicating critical surgical illness.

Barie PS, Hydo LJ, Eachempati SR.

Surg Infect (Larchmt). 2004 Summer;5(2):145-59.

PMID:
15353111
9.

Randomized trial of the effect of intravenous paracetamol on inflammatory biomarkers and outcome in febrile critically ill adults.

Honarmand H, Abdollahi M, Ahmadi A, Javadi MR, Khoshayand MR, Tabeefar H, Mousavi S, Mahmoudi L, Radfar M, Najafi A, Mojtahedzadeh M.

Daru. 2012 Aug 28;20(1):12. doi: 10.1186/2008-2231-20-12.

10.

Effect of intravenous propacetamol on blood pressure in febrile critically ill patients.

Hersch M, Raveh D, Izbicki G.

Pharmacotherapy. 2008 Oct;28(10):1205-10. doi: 10.1592/phco.28.10.1205.

PMID:
18823215
11.

A prospective randomized study to evaluate the antipyretic effect of the combination of acetaminophen and ibuprofen in neurological ICU patients.

Mullins ME, Empey M, Jaramillo D, Sosa S, Human T, Diringer MN.

Neurocrit Care. 2011 Dec;15(3):375-8. doi: 10.1007/s12028-011-9533-8.

PMID:
21503807
12.

Fever effects and treatment in critical care: literature review.

Kiekkas P, Aretha D, Bakalis N, Karpouhtsi I, Marneras C, Baltopoulos GI.

Aust Crit Care. 2013 Aug;26(3):130-5. doi: 10.1016/j.aucc.2012.10.004. Epub 2012 Nov 28. Review.

PMID:
23199670
13.

Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system.

Diringer MN; Neurocritical Care Fever Reduction Trial Group.

Crit Care Med. 2004 Feb;32(2):559-64.

PMID:
14758179
14.

Clinical trial of an air-circulating cooling blanket for fever control in critically ill neurologic patients.

Mayer S, Commichau C, Scarmeas N, Presciutti M, Bates J, Copeland D.

Neurology. 2001 Feb 13;56(3):292-8.

PMID:
11171891
15.

Hydroxyethyl starch for fluid resuscitation in critically ill patients.

Bagshaw SM, Chawla LS.

Can J Anaesth. 2013 Jul;60(7):709-13. doi: 10.1007/s12630-013-9936-4. Epub 2013 Apr 20.

PMID:
23604905
16.

Acetaminophen for Fever in Critically Ill Patients with Suspected Infection.

Young P, Saxena M, Bellomo R, Freebairn R, Hammond N, van Haren F, Holliday M, Henderson S, Mackle D, McArthur C, McGuinness S, Myburgh J, Weatherall M, Webb S, Beasley R; HEAT Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group.

N Engl J Med. 2015 Dec 3;373(23):2215-24. doi: 10.1056/NEJMoa1508375. Epub 2015 Oct 5.

17.

Symptomatic intravenous antipyretic therapy: efficacy of metamizol, diclofenac, and propacetamol.

Oborilová A, Mayer J, Pospísil Z, Korístek Z.

J Pain Symptom Manage. 2002 Dec;24(6):608-15.

PMID:
12551812
18.

Randomized trial of the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response.

Gozzoli V, Treggiari MM, Kleger GR, Roux-Lombard P, Fathi M, Pichard C, Romand JA.

Intensive Care Med. 2004 Mar;30(3):401-7. Epub 2004 Jan 13.

PMID:
14722642
19.

Combined and alternating paracetamol and ibuprofen therapy for febrile children.

Wong T, Stang AS, Ganshorn H, Hartling L, Maconochie IK, Thomsen AM, Johnson DW.

Evid Based Child Health. 2014 Sep;9(3):675-729. doi: 10.1002/ebch.1978. Review.

PMID:
25236309
20.

Cooling by convection vs cooling by conduction for treatment of fever in critically ill adults.

Creechan T, Vollman K, Kravutske ME.

Am J Crit Care. 2001 Jan;10(1):52-9.

PMID:
11153185

Supplemental Content

Support Center